Reporting Manager
Squadron Master Fund LP
Symbol
LPCN
Shares outstanding
5,578,947 shares
Disclosed Ownership
530,000 shares
Ownership
9.5%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 11:49:06 UTC
Date of event
31 Dec 2025
Previous filing
23 Dec 2025

Quoteable Key Fact

"Squadron Capital Management LLC disclosed 9.5% ownership in Lipocine Inc. Common Stock, par value $0.0001 per share (LPCN) on 31 Dec 2025."

Quick Takeaways

  • Squadron Capital Management LLC filed SCHEDULE 13G/A for Lipocine Inc. Common Stock, par value $0.0001 per share (LPCN).
  • Disclosed ownership: 9.5%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 23 Dec 2025.
  • Current filing was accepted on 17 Feb 2026, 11:49.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Squadron Master Fund LP 9.5% 530,000 0 530,000 /s/ Matthew Sesterhenn Partner, Squadron Partners LLC, its General Partner
Squadron Capital Management LLC 9.5% 530,000 0 530,000 /s/ Matthew Sesterhenn Partner
Matthew Sesterhenn 9.5% 530,000 0 530,000 /s/ Matthew Sesterhenn Matthew Sesterhenn
William Blank 9.5% 530,000 0 530,000 /s/ William Blank William Blank